| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794575 | Ophthalmology Retina | 2018 | 6 Pages |
Abstract
Unlike typical AMD, PCV progresses without typical features such as drusen or pigmentary abnormality. Baseline AREDS score was less likely to predict progression of the fellow eye to advanced-stage disease in PCV compared with typical AMD. Therefore, the globally recognized risk-scoring AREDS system may not be applicable in Asia, where PCV is a prevalent subtype of AMD.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Miin MD, PhD, Yuri MD, Hyun Joon MD, ScD, Joan W. MD, Hyoung Jun MD,